PT Darya-Varia Laboratoria Tbk (DVLA.JK)
IDR 1600.0
(-1.23%)
IDR 1600.0
(-1.23%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.47 Billion IDR | -21.91% |
| 2022 | 1.88 Billion IDR | -91.79% |
| 2021 | 22.98 Billion IDR | 2224.81% |
| 2020 | 988.53 Million IDR | 0.0% |
| 2019 | - IDR | 0.0% |
| 2018 | - IDR | 0.0% |
| 2017 | - IDR | 0.0% |
| 2016 | - IDR | 0.0% |
| 2015 | - IDR | 0.0% |
| 2014 | - IDR | -100.0% |
| 2013 | 11.15 Billion IDR | 0.0% |
| 2012 | - IDR | 0.0% |
| 2011 | - IDR | 0.0% |
| 2010 | - IDR | 0.0% |
| 2009 | - IDR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 443.58 Million IDR | -8.58% |
| 2024 Q1 | 1.36 Billion IDR | -7.19% |
| 2024 Q2 | 1.26 Billion IDR | -7.83% |
| 2023 Q4 | 1.47 Billion IDR | -6.65% |
| 2023 Q1 | 1.78 Billion IDR | -5.39% |
| 2023 Q2 | 1.68 Billion IDR | -5.76% |
| 2023 FY | 1.47 Billion IDR | -21.91% |
| 2023 Q3 | 1.57 Billion IDR | -6.17% |
| 2022 Q1 | 17.71 Billion IDR | -22.9% |
| 2022 Q2 | 1.81 Billion IDR | -89.73% |
| 2022 Q3 | 2.58 Billion IDR | 42.1% |
| 2022 Q4 | 1.88 Billion IDR | -26.98% |
| 2022 FY | 1.88 Billion IDR | -91.79% |
| 2021 Q1 | 541.72 Million IDR | -45.2% |
| 2021 Q4 | 22.98 Billion IDR | -21.25% |
| 2021 Q3 | 29.18 Billion IDR | 6316.48% |
| 2021 Q2 | 454.82 Million IDR | -16.04% |
| 2021 FY | 22.98 Billion IDR | 2224.81% |
| 2020 Q4 | 988.53 Million IDR | -64.16% |
| 2020 Q1 | 3.77 Billion IDR | 0.0% |
| 2020 Q2 | 3.76 Billion IDR | -0.29% |
| 2020 FY | 988.53 Million IDR | 0.0% |
| 2020 Q3 | 2.75 Billion IDR | -26.7% |
| 2019 FY | - IDR | 0.0% |
| 2019 Q2 | - IDR | 0.0% |
| 2019 Q4 | - IDR | 0.0% |
| 2019 Q1 | - IDR | 0.0% |
| 2019 Q3 | - IDR | 0.0% |
| 2018 Q3 | - IDR | 0.0% |
| 2018 Q2 | - IDR | 0.0% |
| 2018 FY | - IDR | 0.0% |
| 2018 Q1 | - IDR | 0.0% |
| 2018 Q4 | - IDR | 0.0% |
| 2017 Q1 | - IDR | 0.0% |
| 2017 Q2 | - IDR | 0.0% |
| 2017 Q3 | - IDR | 0.0% |
| 2017 Q4 | - IDR | 0.0% |
| 2017 FY | - IDR | 0.0% |
| 2016 FY | - IDR | 0.0% |
| 2016 Q4 | - IDR | 0.0% |
| 2016 Q2 | - IDR | 0.0% |
| 2016 Q3 | - IDR | 0.0% |
| 2016 Q1 | - IDR | 0.0% |
| 2015 Q3 | - IDR | 0.0% |
| 2015 FY | - IDR | 0.0% |
| 2015 Q4 | - IDR | 0.0% |
| 2015 Q1 | - IDR | 0.0% |
| 2015 Q2 | - IDR | 0.0% |
| 2014 Q1 | - IDR | -100.0% |
| 2014 Q3 | - IDR | 0.0% |
| 2014 Q4 | - IDR | 0.0% |
| 2014 Q2 | - IDR | 0.0% |
| 2014 FY | - IDR | -100.0% |
| 2013 Q2 | - IDR | 0.0% |
| 2013 Q3 | - IDR | 0.0% |
| 2013 Q4 | 11.15 Billion IDR | 0.0% |
| 2013 FY | 11.15 Billion IDR | 0.0% |
| 2013 Q1 | - IDR | 0.0% |
| 2012 Q4 | - IDR | 0.0% |
| 2012 FY | - IDR | 0.0% |
| 2012 Q3 | - IDR | 0.0% |
| 2011 FY | - IDR | 0.0% |
| 2010 FY | - IDR | 0.0% |
| 2009 FY | - IDR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PT Merck Tbk | 18.13 Billion IDR | 91.87% |
| PT Phapros, Tbk | 802.57 Billion IDR | 99.816% |
| PT Pyridam Farma Tbk | 986.99 Billion IDR | 99.851% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 9.39 Billion IDR | 84.302% |
| PT Tempo Scan Pacific Tbk | 1116.39 Billion IDR | 99.868% |